MARKET

NHWK

NHWK

NightHawk
AMEX
0.8800
+0.0300
+3.53%
Closed 15:49 03/24 EDT
OPEN
0.8500
PREV CLOSE
0.8500
HIGH
0.8900
LOW
0.8500
VOLUME
17.79K
TURNOVER
6.55K
52 WEEK HIGH
3.420
52 WEEK LOW
0.7500
MARKET CAP
22.58M
P/E (TTM)
-0.4998
1D
5D
1M
3M
1Y
5Y
NightHawk Biosciences Says On March 17, Board Concluded Financial Statements For Quarters Ended June 30, Sept. 30, 2022 Should No Longer Be Relied Upon; Errors Results In Net Loss Being Overstated
Benzinga · 2d ago
BRIEF-Nighthawk Biosciences -On March 17, Board Concluded Financial Statements For The Quarter Ended June 30, 2022 Should No Longer Be Relied Upon
Reuters · 2d ago
NightHawk Biosciences GAAP EPS of -$0.51 misses by $0.16, revenue of $6M beats by $5.03M
Seekingalpha · 11/15/2022 06:00
BRIEF-NightHawk Biosciences Provides Third Quarter 2022 Business Update
Reuters · 11/14/2022 21:43
NightHawk Biosciences Q3 EPS $(0.51) Down From $(0.30) YoY, Sales $6.00M Up From $501.57K YoY
Benzinga · 11/14/2022 21:38
'NightHawk Biosciences (formerly Heat Biologics) has received a Notice of Allowance for its US patent application 16/497,672 titled "INTRATUMORAL VACCINATION (FOR THE TREATMENT OF TUMORS)' - PatentGrants
https://twitter.com/PatentGrants/status/1568265493496365056   https://patentcenter.uspto.gov/applications/16497672/ifw/docs 
Benzinga · 09/09/2022 15:54
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers
Benzinga · 08/24/2022 09:56
BRIEF-NightHawk Biosciences Announces Buildout Of Advanced Biosafety Level 2 Laboratory
BRIEF-NightHawk Biosciences Announces Buildout Of Advanced Biosafety Level 2 Laboratory
Reuters · 08/23/2022 11:36
More
About NHWK
NightHawk Biosciences, Inc., formerly Heat Biologics, Inc., is a fully integrated biopharmaceutical company. The Company specializes in the end-to-end development and commercialization of therapies that arm the immune system against a range of diseases including cancer and infectious disease. It focuses on drug development through its integrated ecosystem of subsidiary companies, which includes Skunkworx Bio (Skunkworx), Heat Biologics (Heat), Pelican Therapeutics (Pelican), Scorpion Biological Services (Scorpion) and Elusys Therapeutics (Elusys). It offers three technology platform, namely gp96, which leverages the immune stimulatory properties of the heat shock protein gp96 to induce the immune system’s own response against cancer and infectious disease; TNFRSF25, which targets the T cell co-stimulator TNFRSF25 to regulate inflammation and immunosuppression, and RapidVax designed to induce immunological memory against emerging biological threats and accelerate timeline to the clinic.

Webull offers kinds of NightHawk Biosciences Inc stock information, including AMEX:NHWK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NHWK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NHWK stock methods without spending real money on the virtual paper trading platform.